Q8BN58
Gene name |
Arhgap28 (Kiaa1314) |
Protein name |
Rho GTPase-activating protein 28 |
Names |
Rho-type GTPase-activating protein 28 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:268970 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q8BN58
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q8BN58-F1 | Predicted | AlphaFoldDB |
30 variants for Q8BN58
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs221991421 | 66 | N>D | No | EVA | |
rs224248434 | 72 | D>Y | No | EVA | |
rs217472608 | 95 | S>A | No | EVA | |
rs248181508 | 106 | A>T | No | EVA | |
rs3389484992 | 184 | E>* | No | EVA | |
rs3389478250 | 204 | K>N | No | EVA | |
rs3389457093 | 212 | T>R | No | EVA | |
rs212980699 | 223 | S>N | No | EVA | |
rs3407917244 | 247 | S>Q | No | EVA | |
rs3407917228 | 249 | L>P | No | EVA | |
rs51413453 | 256 | A>P | No | EVA | |
rs3389457091 | 260 | N>D | No | EVA | |
rs51326721 | 300 | V>M | No | EVA | |
rs3389478413 | 325 | I>F | No | EVA | |
rs3389457081 | 383 | G>E | No | EVA | |
rs3389444514 | 387 | T>R | No | EVA | |
rs3412749453 | 408 | K>I | No | EVA | |
rs3389470058 | 413 | V>SDG* | No | EVA | |
rs3389425768 | 418 | L>V | No | EVA | |
rs3412781672 | 420 | S>* | No | EVA | |
rs3389478300 | 423 | I>M | No | EVA | |
rs3389470073 | 459 | A>T | No | EVA | |
rs3389425706 | 481 | P>H | No | EVA | |
rs3389479190 | 513 | D>G | No | EVA | |
rs3389492706 | 599 | M>I | No | EVA | |
rs3389470327 | 610 | K>T | No | EVA | |
rs3389477502 | 673 | L>Q | No | EVA | |
rs3389477469 | 678 | Y>F | No | EVA | |
rs3389470329 | 699 | G>V | No | EVA | |
rs3389436161 | 702 | I>M | No | EVA |
No associated diseases with Q8BN58
4 regional properties for Q8BN58
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 159 - 479 | IPR000719 |
active_site | Serine/threonine-protein kinase, active site | 283 - 295 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 165 - 188 | IPR017441 |
domain | Dual specificity tyrosine-phosphorylation-regulated kinase 1A/1B, catalytic domain | 148 - 484 | IPR044131 |
1 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
1 GO annotations of molecular function
Name | Definition |
---|---|
GTPase activator activity | Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP. |
5 GO annotations of biological process
Name | Definition |
---|---|
negative regulation of GTP binding | Any process that stops, prevents or reduces the frequency, rate or extent of GTP binding. |
negative regulation of stress fiber assembly | Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. |
regulation of actin filament polymerization | Any process that modulates the frequency, rate or extent of the assembly of actin filaments by the addition of actin monomers to a filament. |
regulation of small GTPase mediated signal transduction | Any process that modulates the frequency, rate or extent of small GTPase mediated signal transduction. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
4 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A7E300 | DLC1 | Rho GTPase-activating protein 7 | Bos taurus (Bovine) | SS |
Q9P2N2 | ARHGAP28 | Rho GTPase-activating protein 28 | Homo sapiens (Human) | PR |
Q9R0Z9 | Dlc1 | Rho GTPase-activating protein 7 | Mus musculus (Mouse) | SS |
Q63744 | Dlc1 | Rho GTPase-activating protein 7 | Rattus norvegicus (Rat) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MEVEDSGGVV | LTAYHSHARS | QPQGAEPRCA | SRASHPLSRK | SIPRCRRINR | MLSNESLHPP |
70 | 80 | 90 | 100 | 110 | 120 |
SFSRSNSQAS | VDSSASMEEF | LREIESIKES | SVGASQEQPP | TAAAAAAEVK | PVDEGELEAE |
130 | 140 | 150 | 160 | 170 | 180 |
WLQDVGLSTL | ISGNEEEDGK | ALLSTLTRTQ | AAAVKKRYNT | YTQTLRKKNK | QPVRDVRDIF |
190 | 200 | 210 | 220 | 230 | 240 |
GVSESPPSDS | CEHATQLDGT | KEEKDLPGVT | KTSRPLPDDA | SLSSTTLSNG | AQDEEGGFVA |
250 | 260 | 270 | 280 | 290 | 300 |
LQSGSVSILE | AIPDIAVHTN | GSADAEQSVQ | STLSDDDYHG | KNVPAEAEEL | SFEVSYSEMV |
310 | 320 | 330 | 340 | 350 | 360 |
TEMPDRNKWK | KSDIKKEDYV | LTKFIIQKTR | FGLTETGDLS | VEDMKKIRHL | SLIELTAFFD |
370 | 380 | 390 | 400 | 410 | 420 |
AFGIQLKRNK | TERVRGRDNG | IFGVPLTVLL | DNDRKKDPAV | KVPLVLQKFF | QKVEESGLES |
430 | 440 | 450 | 460 | 470 | 480 |
EGIFRLSGCT | AKVKQYREEL | DARFNADKFK | WDKMCHREAA | VMLKAFFREL | PTSLFPVEYI |
490 | 500 | 510 | 520 | 530 | 540 |
PAFISLMERG | PDIKVQFQAL | HLMVMALPDA | NRDTAQALMA | FFNKVIANES | KNRMNLWNIS |
550 | 560 | 570 | 580 | 590 | 600 |
TVMAPNLFFS | RSKHSDCEEL | LLANTATHII | RLMLKYQKIL | WKVPSFLITQ | VRRMNEATML |
610 | 620 | 630 | 640 | 650 | 660 |
LKKQLPSMKK | LLRRKTLDRE | VSILKTSKVP | QKSPSSRRMS | DVPEGVIRVH | APLLSKVSMA |
670 | 680 | 690 | 700 | 710 | 720 |
IQLNSQTKAK | DILAKFQYEN | SHGSSEHIKM | QNQRLYEVGG | NIGQHCLDPD | AYILDVYHIN |
PHAEWVIKP |